Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Send this study to a contact
1
Your personal information
Your name
Your e-mail
Send me a copy
2
Your recipient's information
The name of your contact
Your contact email
3
Your message
Votre message
A multicenter, randomized, double-blind, placebo-controlled Phase IIb Efficacy Study of Vx-001, a peptide-based cancer vaccine aimed to maintain disease control after first line treatment in HLA-A*0201 positive patients with TERT positive NSCLC (stage IV or recurrent stage I-III) https://kusajili.fr:443/Trial/9L8cRa5BYkSlKDryn1DVaQ%24a-multicenter-randomized-double-blind-placebo-controlled-phase-iib-efficacy-study-of-vx-001-a-peptide-based-cancer-vaccine-aime
I have read and accept the terms of use of the site and the Privacy Policy
Send your message